Therefore, our study aimed to determine whether indisulam can also serve as an effective drug for treating T-ALL and to investigate the critical role of its target RBM39 and the key molecular mechanisms underlying its efficacy. The gene discussed is RBM39; the disease is acute lymphoblastic leukemia.